Table 2.
Distribution of IgM/IgG among overall convalescent patients.
| IgG positive number (%) | P | IgG antibody levels (mean,95%CI) | P | IgM positive number (%) | P | IgM antibody levels (mean,95%CI) | P | |
|---|---|---|---|---|---|---|---|---|
| Overall | 255(80.19) | 9.73(8.28,11.19) | 65(20.44) | 4.85(2.85,6.86) | ||||
| Gender | 0.227 | 0.520 | 0.644 | 0.564 | ||||
| Male | 116(77.33) | 9.21(6.99,11.44) | 29(19.33) | 4.20(1.79,6.61) | ||||
| Female | 139(82.74) | 10.17(8.24,12.10) | 36(21.43) | 5.38(2.21,8.55) | ||||
| Age (ys) | 0.010* | 0.280 | 0.401 | 0.082 | ||||
| <20 | 9(52.94) | 4.70(2.57,6.82) | 1(5.88) | 1.44 | ||||
| 20~ | 23(71.88) | 10.60(3.44,17.77) | 8(25.00) | 2.56(1.17,3.95) | ||||
| 30~ | 61(77.22) | 7.54(5.84,9.24) | 17(21.52) | 3.47(1.85,5.09) | ||||
| 40~ | 45(83.33) | 10.71(7.81,13.61) | 15(27.78) | 3.74(1.87,5.61) | ||||
| 50~ | 67(90.54) | 11.77(7.98,15.56) | 13(17.57) | 11.02(2.06,19.97) | ||||
| ≥60 | 50(80.65) | 9.31(6.75,11.86) | 11(17.74) | 3.21(1.81,4.61) | ||||
| Severity of disease | 0.003** | 0.330 | 0.489 | 0.685 | ||||
| Asymptomatic type | 62(67.39) | 7.33(5.39,9.27) | 17(18.48) | 3.90(1.93,5.88) | ||||
| Mild type | 50(83.33) | 10.26(7.72,12.80) | 13(21.67) | 3.64(2.12,5.16) | ||||
| Normal type | 139(85.80) | 10.60(8.27,12.93) | 33(20.37) | 6.02(2.26,9.79) | ||||
| Severe/Critical type | 4(100.0) | 10.37(2.93,17.82) | 2(50.0) | 1.61(0.92,2.31) | ||||
| SARS-CoV-2 vaccination | 0.130 | 0.007** | 0.226 | 0.801 | ||||
| Unvaccinated | 216(78.83) | 8.90(7.32,10.48) | 53(19.34) | 4.98(2.55,7.40) | ||||
| Vaccinated | 39(88.64) | 14.37(11.02,17.72) | 12(27.27) | 4.31(2.17,6.46) |
P < 0.05 represents significant difference. *p < 0.05; **p < 0.01.